WHO GETS JNJ INFO HERE?
THESE NOTABLE VISITORS ;o)
Regular visitors to the JohnsonAndToxin site include these and many others...
- US SENATE
- World Health Organization
- National Health Service UK
- US Centers for Disease Control
- Department of Defense
- Department of Justice
- US Federal Reserve
- and others from the alphabet soup of government organizations around the world.
This site also regularly receives visitors from:
- offices of the DOW
- The Bank of New York Mellon Corp
- Lloyds Banking Group PLC
- Cantor Fitzgerald & Co.
- Harris Trust & Savings Bank
- BlackRock Financial Management
- The Capital Group
- RBS Securities in US
- Bank of America
- as well as other major financial institutions.
The site has the Honor of being visited by:
- Ernst & Young
- Group M (world's largest media investment group)
- Young & Rubicam PR FIRM
- Porter Novelli PR FIRM
- Grey Group PR FIRM
This site has been visited by numerous educational facilities including:
- India Institute of Management
- Quinnipiac University
- Universitaet Graz
- Baruch College
- University of North Carolina at Chapel Hill
- University of North Carolina at Greensboro
- Lancaster University
- Miami Dade College
- Marymount Manhattan College
- Loyola University
- Punjabi University
- Franciscan University
- Arizona State University
- University of Surrey London
- Loughborough University
- Southern University at New Orleans
- Amrita Vishwa Vidyapeetham University
- Northern Caribbean University
- Louisiana State University
- Hong Kong University of Science and Technology
- Oregon State University
- University of California
- Rutgers University
- Southern New Hampshire University
- Vanderbuilt University
- Macquarie University
- CRI Universite de Nantes - 2 Rue de la Houssiniere
- International Islamic University Of Malaysia
- Baylor University
- Taiwan Academic Network (TANet) Information Center
- Suffolk University
- Pittsburg State University
- Idaho State University
- University of Miami
- University of Hawaii
- University of Colorado
- Duke University
- just to name a few.
And, of course, visitors from Johnson & Johnson servers around the world, Bayer, Synthes, Merck and others.
In addition to the very interesting visitors to the web site, I have been contacted by reporters such as Steven Brill and Jane Akre, lawyers from four countries such as Michael Huttner of the US, Jacquelyn NG from DEACONS in Hong Kong, Charlie Euchner Case Writer & Project Editor Yale School of Management, a variety of whistleblowers including Scott Bartz, one of the convicted (which I cannot disclose publicly) and numerous victims. They are all using the information from the Johnson and Toxin site for their court cases and research projects asking me to do specific research in addition to what is on the site.
Letter to J P Morgan Michael Weinstein RE: $JNJ 3rd quarter 2013 Conference Call
Since Orsinger and Caruso danced around issues of price competition and lack of consumer sales growth and basically said nothing, I figured I'd give him a real answer.
Date Created: 2013, October 17
Keywords: obama, Michael Weinstein, jp morgan, JNJ, invest, stock, financial, analyst
Site accessed 2,714,094 times.
This page accessed 8,024 times.
J. P. Morgan and Company
Healthcare Equipment and Supplies
277 Park Avenue Floor 39
New York, New York 10172
RE: Johnson & Johnson 3rd Quarter Teleconference: 14 October 2013
Dear Michael Weinstein,
My name is Emily Patterson. I am the creator of and researcher for a web site called Johnson and Toxin. After reading the transcript of the 3rd quarter 2013 teleconference with Johnson & Johnson Vice President of Finance, Dominic Caruso and Johnson & Johnson Worldwide Chairman of DePuy Synthes companies, Michel Orsinger, I felt your questions required a little more realistic clarification.
I feel the interesting questions you asked during the teleconference deserved a far deeper, and more accurate, explanation. You were wondering if Dominic Caruso was referring to lower price competition in the U.S., global or a combination.
After recalls of over 100,000 defective hips, TVTMesh, defective knees, anal staplers, and more over the last few years, Johnson & Johnson is paving the way for competitors to surpass the pathetically low quality and testing standards at Johnson & Johnson and subsidiary companies. Johnson & Johnson prices must stay inflated to compensate for billions of dollars in lawsuits and settlements from these known defective devices. This opens the door for companies with higher ethics, standards and quality controls to charge far less for similar products - because they are far superior to the products offered by Johnson & Johnson.
In your statement you mentioned that there was only 1% growth in the Johnson & Johnson Consumer Segment. As you know, the previous CEO, Bill Weldon, allowed Johnson & Johnson facilities to deteriorate to the point of literal urine bottles in closets. Although it was promised that the facilities would be back up and running at the end of last year, excuse after excuse and $100 million later, Johnson & Johnson is still under consent decree with the United States Food and Drug Administration.
In addition, Johnson & Johnson is still experiencing recalls of products in many countries: January, Aveeno Baby Lotion in the U.S.; March, KY Lubricants in the U.S.; May, baby powder in India (with FDA of India shutting down plant); May, Children's Tylenol in South Korea with ensuing product restrictions; June, Yogurt drink in the United Kingdom; September, Children's Motrin in the U.S. So, as you can see, recalls continue to be an issue, reducing sales and potential for growth until Johnson & Johnson finds a way to improve the consistent quality of their products.
One other point you should consider, as consumers become educated as to the risks of cancer associated with certain ingredients in Johnson & Johnson products, especially baby products, many are choosing other safer sources with fewer chemicals to reduce health risks for their children. This is yet another factor reducing consumer sales growth.
I hope this provided a more detailed explanation for your concerns,
Supported ONLY by Gifts...
Please note the lack of squiggling, jiggling ads all over the place. I'm not working for advertisers, I'm working for you. Financial support for this work is provided only
by visitors. Only 1 in every 10,000 or so sends help. It would be nice to see that increase. Gifts accepted securely via PayPal - no PayPal account required.
1. TRANSCRIPT (2013, October 15). Johnson & Johnson's Management Discusses Q3 2013 Results - Earnings Call Transcript. Seeking Alpha. Retrieved from http://seekingalpha.com/article/1746172-johnson-and-johnsons-management-discusses-q3-2013-results-earnings-call-transcript?page=11&p=qanda&l=last